Iris Kliers
Impact in
-
- Diabetes Treatment and Management
- Diet, Metabolism, and Disease
-
- Liver Disease Diagnosis and Treatment
Papers in
-
- Liver Disease Diagnosis and Treatment 8
-
- Metabolism, Diabetes, and Cancer 5
- Co-authors
- Philip N. Newsome (6 shared papers)Mary E. Rinella (2 shared papers)Vlad Ratziu (2 shared papers)Michael Roden (3 shared papers)Elisabetta Bugianesi (3 shared papers)Michelle T. Long (6 shared papers)Mette Skalshøi Kjær (1 shared paper)Arun J. Sanyal (7 shared papers)
- Journals
- Journal of Hepatology (3 papers)Medicine (1 paper)Journal of Travel Medicine (1 paper)JHEP Reports (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- IsraelUnited KingdomUnited States
In The Last Decade
Iris Kliers
13 papers receiving 422 citations
Iris Kliers's Hit Papers
Peers
Comparison fields: 5 of 50
- Endocrinology, Diabetes and Metabolism 138
- Epidemiology 177
- Hepatology 26
- Ophthalmology 22
- Pathology and Forensic Medicine 40
Countries citing papers authored by Iris Kliers
This map shows the geographic impact of Iris Kliers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Kliers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Kliers more than expected).
Fields of papers citing papers by Iris Kliers
This network shows the impact of papers produced by Iris Kliers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Kliers. The network helps show where Iris Kliers may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris Kliers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis Hit paper breakdown → | 2025 | 272 |
| 2 | Semaglutide 2.4 mg in Participants With Metabolic Dysfunction‐Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 Hit paper breakdown → | 2024 | 75 |
| 3 | 2002 | 24 | |
| 4 | 2011 | 20 | |
| 5 | 2016 | 19 | |
| 6 | Listeria Peritonitis in a Patient Treated with Peritoneal Dialysis. | 2016 | 8 |
| 7 | 2023 | 4 | |
| 8 | 2015 | 3 | |
| 9 | 2025 | 2 | |
| 10 | 2024 | 2 | |
| 11 | [Neurocysticercosis in Israel]. | 2010 | 2 |
| 12 | 2024 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2016 | 0 | |
| 15 | 2024 | 0 |
About Iris Kliers
Iris Kliers is a scholar working on Epidemiology, Molecular Biology, Endocrinology, Diabetes and Metabolism, Surgery and Pathology and Forensic Medicine, having authored 15 papers that have together received 434 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), Metabolism, Diabetes, and Cancer (5 papers), Diabetes Treatment and Management (4 papers), Microbial Inactivation Methods (1 paper), Dysphagia Assessment and Management (1 paper), Intestinal and Peritoneal Adhesions (1 paper), Pancreatitis Pathology and Treatment (1 paper) and Listeria monocytogenes in Food Safety (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (138 citations), Epidemiology (177 citations), Hepatology (26 citations), Ophthalmology (22 citations) and Pathology and Forensic Medicine (40 citations). Iris Kliers has collaborated with scholars based in Israel, United Kingdom and United States. Frequent co-authors include Philip N. Newsome, Mary E. Rinella, Vlad Ratziu, Michael Roden, Elisabetta Bugianesi, Michelle T. Long, Mette Skalshøi Kjær, Arun J. Sanyal, Kristiane A. Engebretsen and Gad Segal. Their work appears in journals such as Journal of Hepatology, Medicine, Journal of Travel Medicine, JHEP Reports and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.